Signaling pathways
-
BA2227 JCP174Summary: JCP174 is an inhibitor of palmitoyl protein thioesterase-1 (TgPPT1), a depalmitoylating enzyme in Toxoplasma gondii. - BA2238 TM2-115Summary: TM2-115 inhibits Plasmodium falciparum histone methyltransferase.
- BA2241 R-10015Summary: R-10015, a broad-spectrum antiviral compound for infections, is a highly potent and selective inhibitor that blocks LIMK by binding to the ATP-binding pocket.
- BA2242 SPK-601Summary: SPK-601 (LMV-601) is a phosphatidylcholine-specific phospholipase C inhibitor.
- BA2249 AVG-233Summary: AVG-233 is an orally effective RNA-dependent RNA polymerase inhibitor.
- BA2257 GSK3326595Summary: GSK3326595 is a protein arginine methyltransferase 5 inhibitor.
- BA2258 ZotatifinSummary: Zotatifin (eFT226) is a potent, selective and well-tolerated eIF4A inhibitor.
- BA2262 LP-935509Summary: LP-935509 is an orally potent, selective, ATP-competitive, and blood-brain barrier-crossing inhibitor of junctional protein-2-related kinase 1.
- BA2266 EnoxaparinSummary: Enoxaparin (PK10169) is a low molecular heparin (LMWH) derivative.
- BA2271 Vps34-IN-2Summary: Vps34-IN-2 is a novel, potent and selective inhibitor.